This is simply how it goes. Take a look at the sto
Post# of 72436
![Avatar](/images/ProfileImages/no_avatar_available.jpg)
I could complain about the fact that I have all these shares at $3+ basis, $4+ basis, but the reality is that I was hedging against a sudden rise to $10+ and I would have made the same decision every time, fore IPIX's pipeline is out of this world awesome. It's simply a matter of time when that pipeline value gets returned to us shareholders. There's no debt dangers here, the only danger is dilution - a dilution only concern is rare in the pre-revenue emerging biotech world. At worst the industry standard 'toxic' financing comes into play, I'm thinking something is in the works that makes that concern irrelevant (hint: signed termsheet).
Anyway, don't have the bandwidth these days to post often, but figured I'd post my near the lows thoughts. Cheers!
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)